Venous thromboembolic disease: Which coagulation screening, for whom, when?;La maladie veineuse thrombo-embolique: Quel bilan de coagulation, pour qui, quand?

Revue Medicale de Bruxelles

Volumn 26, Issue 4, 2005, Pages

  Wautrecht, J C ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Screening; Thrombophilia; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PHOSPHOLIPID ANTIBODY;

ANTITHROMBIN DEFICIENCY; ARTICLE; DIAGNOSTIC VALUE; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC RISK; HEMOSTASIS; HUMAN; HYPERHOMOCYSTEINEMIA; LABORATORY TEST; PREDICTION; PROTEIN C DEFICIENCY; SCREENING; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOEMBOLISM;

BLOOD COAGULATION DISORDERS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MASS SCREENING; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 26244433271     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Egeberg O: Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-30
2. British Committee for Standards in Haematology: Guidelines on investigation and management of thrombophilia. J Clin Path 1990; 43: 703-10
3. Walker ID: Masterclass series in peripheral arterial disease. Inherited thrombophilia. Vasc Med 2004; 9: 219-21
4. Rosendaal FR: Venous thrombosis: a multicausal cause. Lancet 1999; 353: 1167-73
5. Lane SA, Mannucci PM, Bauer KA et al: Inherited thrombophilia: Part 2. Thromb Haemost 1996; 76: 824-34
6. Rosendaal FR: Risk factors for venous thrombotic disease. Thromb Haemost 1999; 82: 616-9
7. Bertina RM, Koeleman BPC, Koster T et al: Mutation in blood coagulation factor V association with resistance to activated protein C. Nature 1994; 369: 64-7
8. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH: High risk of thrombosis in patients homozygous for F V Leiden (activated protein C resistance). Blood 1995; 85: 1504-8
9. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703
10. Haverkate F, Samama M: Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995; 73: 151-61
11. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR: Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis. Lancet 1995; 345: 152-5
12. Den Heijer M, Lewington S, Clarke R: Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005; 3: 292-9
13. Wilson WA, Gharavi AE, Koike T et al: International consensus statement on preliminary classification criteria for definitive antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 79: 3-58
14. Menon KV, Shah V, Kamath PS: The Budd-Chiari syndrome. N Engl J Med 2004; 350: 578-85
15. López JA, Kearon C, Lee AYY: Deep Venous Thrombosis. Hematology. Am Soc Hematol Educ Program 2004; 439-56
16. Bauer KA: The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med 2001; 135: 367-73
17. Baglin T: Management of thrombophilia: who to screen? Pathophysiol Haemost Thromb 2003/2004; 33: 401-4
18. Walker ID, Greaves M, Preston FE: Guideline: Investigation and management of heritable thrombophilia. Br J Haemat 2001; 114: 512-28